Vioxx liens cut as lawyers request fee hike

Two Vioxx settlement news bits: Some 100 insurers have agreed to reduce the medical liens on Vioxx claimants, cutting the amount of their settlement cash that will be diverted to hospital bills; meanwhile, Vioxx plaintiff lawyers are asking a judge to nullify a cap on their contingency fees. Release | Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.